Venture Above the Charles Summer Soiree

Sponsored Event | June.26.2024 | 5:00pm - 8:30pm (Eastern Standard Time)

Orrick Boston

Techstars, The AI Furnace and Orrick are hosting the second annual Venture Above the Charles Summer Soiree.

Join fellow entrepreneurs and investors at Orrick’s Back Bay office perched above the Charles for a unique opportunity to connect with others in the ecosystem in a relaxed atmosphere over delicious, local food and refreshments.

Fore more information, please reach out to Amy Huang.

388459

Practice:

  • Technology & Innovation Sector
  • Life Sciences & HealthTech Sector
  • Technology Companies Group
  • Corporate Governance
  • Mergers & Acquisitions
  • Capital Markets

Gregg Griner Partner

Boston

Gregg represents companies in all stages of their life cycles, from start-ups to public companies, and in a variety of industries including, software, hardware, information services, financial services, financial technology, consumer goods, fashion, media, energy, medical devices and pharmaceuticals. He advises these companies in many aspects of their businesses including financings, corporate governance, employment matters, acquisitions, divestitures, licensing and distribution arrangements, and joint ventures and strategic partnerships.

Gregg also represents venture capital firms in their formation, fundraising efforts and maintenance, as well as in their investments in early and later stage operating companies and in complex leveraged transactions and restructurings. Gregg has worked with a number of leading technology and life science companies in connection with their initial and follow-on public offerings, M&A activities and leading investment banks in their underwriting of public equity and debt offerings.

Gregg has received praise from numerous peer publications, including Best Lawyers (Technology Law, Massachusetts) and Massachusetts Lawyers Weekly (Go-To Lawyer for Healthcare/Life Sciences).

429176

Practice:

  • Technology Companies Group
  • Mergers & Acquisitions

Benjamin Howe Partner

Boston

Ben represents startup companies through all aspects of their life cycle as well as advises both financial and strategic venture capital investors.

He has worked with entrepreneurs to form hundreds of startup companies and has closed an even larger number of domestic and international venture capital financings, including early seed investments, initial and growth equity rounds, bridge financings, venture debt, large late-stage equity rounds and complex strategic investments.

Ben’s practice also includes representation of buyers and sellers in deals ranging from sales and acquisitions of early stage emerging companies to multibillion-dollar cross-border transactions.

Ben has held positions with a university venture fund, a large venture-backed startup and a national emerging company incubator. He also served as General Faculty at the University of Virginia.

In addition to his representation of startup companies and investors, Ben is also an adjunct professor at Boston University School of Law, where he teaches a spring semester seminar on venture-backed startups.

391594

Practice:

  • Technology & Innovation Sector
  • Capital Markets
  • Corporate Governance
  • Technology Companies Group
  • Life Sciences & HealthTech
  • Special Purpose Acquisition Companies (SPACs)
  • Mergers & Acquisitions

Albert Vanderlaan Partner

Boston

Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, de-SPAC transactions, SPAC IPOs, venture financings and mergers and acquisitions. He also regularly advises public and private companies and their boards of directors on corporate governance issues.

Albert's clients include public and private companies in technology, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.

Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”

408599

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Andy Bloom Senior Associate

Washington, D.C.; Boston

Andy advises high growth technology companies, startup founders, private funds and other institutional investors on a broad range of corporate transactions across industries. He has extensive experience in a broad range of corporate and transactional matters, advising companies from formation to exit on formation, governance, and financing matters, and private funds and institutional investors on venture capital, growth equity and private equity investments. Andy works closely with clients to provide strategic insights and outside general counsel services, advising clients on day-to-day governance, equity compensation and general commercial matters.

Andy also has extensive experience advising sponsors of private investment funds on their formation, regulatory compliance, and fundraising activities, as well as institutional investors in connection with various aspects of their investment programs, including investments in private investment funds, co-investments and complex secondaries transactions.

George Pothoulakis Senior Associate

Boston

George advises start-up, emerging growth and public companies, as well as a number of leading venture capital firms, in all areas of general corporate/securities law and in a variety of different transactions (ex. venture financings, M&A and public offerings). His practice spans the entire corporate lifecycle, from inception to exit/liquidity, and includes the representation of companies from various industries (ex. biotech, pharma, digital health, consumer internet and software). George regularly serves as principal outside counsel to his clients and takes great pride in providing them with thoughtfully tailored advice on complex corporate and strategic matters.

In addition to his extensive experience in private practice, George recently served as Director & Senior Counsel of the Boehringer Ingelheim Venture Fund, where he oversaw and supported all legal aspects of the venture fund's investment activities in the United States and Canada.  During his time there, George also supported the venture fund's parent pharma company as lead counsel in several global financing and M&A transactions.

During law school, George was Executive Editor of the Washington University Law Review and also served as a Judicial Extern to the Honorable Kim McLane Wardlaw at the United States Court of Appeals for the Ninth Circuit.

413159

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Chapin Scaggs Managing Associate

Boston

Chapin focuses on representing high-growth technology companies of all sizes throughout their life-cycles-- from general formation and corporate governance through to venture capital and private equity financings.  He also advises investors and venture capital firms in their investments in early and high growth technology companies.